Načítá se...
Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis
BACKGROUND: Higher doses of erythropoiesis-stimulating agents (ESA) have been associated with an increased risk of adverse outcomes in adults with chronic kidney disease (CKD) and end-stage kidney disease (ESRD), but to our knowledge no trials have been performed in children. We examined the associa...
Uloženo v:
| Vydáno v: | Pediatr Nephrol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4448694/ https://ncbi.nlm.nih.gov/pubmed/24794833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-014-2820-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|